[Federal Register: May 2, 2005 (Volume 70, Number 83)]
[Notices]               
[Page 22704]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02my05-95]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 18, 2005, Lilly Del 
Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, 
Puerto Rico 00680, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Dextropropoxyphene (9273), a basic class of controlled substance listed 
in Schedules II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than July 1, 2005.

    Dated: April 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-8694 Filed 4-29-05; 8:45 am]

BILLING CODE 4410-09-P